Double-blind Study to Evaluate the PK, Efficacy, Safety and Immunogenicity of MB12 Versus Keytruda® in Stage IV NSCLC
Clinical trial NCT05668650 · UNKNOWN
Trial details
- NCT number
- NCT05668650
- Sponsor
- Laboratorio Elea Phoenix S.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-15
- Primary completion
- 2024-08-01
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.